1977
DOI: 10.1016/0010-7824(77)90083-x
|View full text |Cite
|
Sign up to set email alerts
|

Clinical trial with subdermal implants of the progestin R-2323

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

1978
1978
1991
1991

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 13 publications
(2 citation statements)
references
References 4 publications
0
2
0
Order By: Relevance
“…Progestogen only preparations were observed to cause less impairment of glucose tolerance as compared to estrogen-progestogen combination preparations [6,7].…”
Section: Introductionmentioning
confidence: 89%
See 1 more Smart Citation
“…Progestogen only preparations were observed to cause less impairment of glucose tolerance as compared to estrogen-progestogen combination preparations [6,7].…”
Section: Introductionmentioning
confidence: 89%
“…With subdermal implants of R-2323, altered liver function tests were observed [6], but not with implants of other progestogens, including Norplant R (six capsules) [7,8].…”
Section: Introductionmentioning
confidence: 96%